These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 36507223)
1. Ad26.COV2.S priming provided a solid immunological base for mRNA-based COVID-19 booster vaccination. Geers D; Sablerolles RSG; van Baarle D; Kootstra NA; Rietdijk WJR; Schmitz KS; Gommers L; Bogers S; Nieuwkoop NJ; van Dijk LLA; van Haren E; Lafeber M; Dalm VASH; Goorhuis A; Postma DF; Visser LG; Huckriede ALW; Sette A; Grifoni A; de Swart RL; Koopmans MPG; van der Kuy PHM; GeurtsvanKessel CH; de Vries RD; iScience; 2023 Jan; 26(1):105753. PubMed ID: 36507223 [TBL] [Abstract][Full Text] [Related]
2. Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming. Sablerolles RSG; Rietdijk WJR; Goorhuis A; Postma DF; Visser LG; Geers D; Schmitz KS; Garcia Garrido HM; Koopmans MPG; Dalm VASH; Kootstra NA; Huckriede ALW; Lafeber M; van Baarle D; GeurtsvanKessel CH; de Vries RD; van der Kuy PHM; N Engl J Med; 2022 Mar; 386(10):951-963. PubMed ID: 35045226 [TBL] [Abstract][Full Text] [Related]
3. Differential immunogenicity of homologous versus heterologous boost in Ad26.COV2.S vaccine recipients. Khoo NKH; Lim JME; Gill US; de Alwis R; Tan N; Toh JZN; Abbott JE; Usai C; Ooi EE; Low JGH; Le Bert N; Kennedy PTF; Bertoletti A Med; 2022 Feb; 3(2):104-118.e4. PubMed ID: 35072129 [TBL] [Abstract][Full Text] [Related]
4. Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study. Costa Clemens SA; Weckx L; Clemens R; Almeida Mendes AV; Ramos Souza A; Silveira MBV; da Guarda SNF; de Nobrega MM; de Moraes Pinto MI; Gonzalez IGS; Salvador N; Franco MM; de Avila Mendonça RN; Queiroz Oliveira IS; de Freitas Souza BS; Fraga M; Aley P; Bibi S; Cantrell L; Dejnirattisai W; Liu X; Mongkolsapaya J; Supasa P; Screaton GR; Lambe T; Voysey M; Pollard AJ; Lancet; 2022 Feb; 399(10324):521-529. PubMed ID: 35074136 [TBL] [Abstract][Full Text] [Related]
5. Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infection. Moyo-Gwete T; Richardson SI; Keeton R; Hermanus T; Spencer H; Manamela NP; Ayres F; Makhado Z; Motlou T; Tincho MB; Benede N; Ngomti A; Baguma R; Chauke MV; Mennen M; Adriaanse M; Skelem S; Goga A; Garrett N; Bekker LG; Gray G; Ntusi NAB; Riou C; Burgers WA; Moore PL PLoS Pathog; 2023 Nov; 19(11):e1011772. PubMed ID: 37943890 [TBL] [Abstract][Full Text] [Related]